EMEA-002366-PIP01-18
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0311/2018
|
| PIP number |
EMEA-002366-PIP01-18
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Prevention of cardiovascular events
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
SmartGenRx Pty Ltd
Tel. +61 (2)80524375 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|